AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr Goodhybe who wrote (921)	7/25/1999 7:22:00 PM
From: Mike McFarland	Read Replies (1) of 1728

(GSAC) Thread--for Celera/Venter fans... tigr.org _______________________ Two snips from the site. June 10, 1999 The database for the Mycobacterium tuberculosis clinical strain CDC1551 genome sequence is available. TIGR Speaker Series--one reason to live in DC tigr.org Recent speaker David Baltimore From the MIT website David Baltimore's discovery in 1970 of reverse transcriptase, an enzyme that catalyzes the conversion of RNA to DNA, advanced the means of DNA synthesis and helped form the basis of modern genetic engineering, the workhorse of biotechnology. Baltimore shared the Nobel Prize in 1975 for this discovery. Baltimore's later work in retrovirus vectors fundamentally contributed to the development of gene therapy, the "second generation" of the biotechnology revolution with great potential for treating diseases at their root, genetic level. and Caltech caltech.edu --Maybe Baltimore just strikes me as a much more interesting fellow than Craig Venter: Is that story true about the halls leading to his office being lined with pictures of Venter from magazine covers? Anybody see a conflict of interest being Chairman of TIGR and President of Celera?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next